Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Androtriol (YC-6) injection after mechanical thrombectomy in acute ischemic stroke
ChiCTR2500113452Phase 2Completed
- Sponsor
- Army Specialized Medical Center
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Androtriol (YC-6) arm with Placebo arm (2 arms). Primary endpoint: Good functional outcome at 90 days. Started Nov 2025; status: completed.
02
Drugs
androtriol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2500113452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113452.